Cytotoxic Effects Of Selective Inhibitor 'Aurora Kinase B' On Viability And Metabolic Features Of Human Promyelocytic Leukemia Cell Line
Background and Aim: A goal of modern cancer research is to reach targeted therapies with drugs having fewer side effects. AZD1152 is a highly specific inhibitor of Aurora Kinase B, which leads to the programmed cell death by different mechanisms. The aim of this study was to evaluate the effects of...
Gorde:
Egile Nagusiak: | , , , , , |
---|---|
Formatua: | Liburua |
Argitaratua: |
Tehran University of Medical Sciences,
2013-09-01T00:00:00Z.
|
Gaiak: | |
Sarrera elektronikoa: | Connect to this object online. |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
Internet
Connect to this object online.3rd Floor Main Library
Sailkapena: |
A1234.567 |
---|---|
Alea 1 | Eskuragarri |